| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $894.4M | -2.2% |
| Cost of Revenue | $155.4M | -40.9% |
| Gross Profit | $738.9M | +13.4% |
| R&D Expense | $144.4M | -1.2% |
| SG&A Expense | $112.1M | -26.6% |
| Operating Income | $13.4M | -58.9% |
| Pre-tax Income | $24.7M | -52.3% |
| Income Tax | $3.7M | -87.6% |
| Net Income | $21.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $304.2M | +4.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $44.2M | +10.7% |
| Inventory | $338K | +2.1% |
| Current Assets | $391.2M | +0.0% |
| Total Assets | $824.5M | -10.3% |
| Current Liabilities | $93.1M | -19.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $255.5M | +105.2% |
| Capital Expenditures | $75.2M | +206.0% |
| Investing Cash Flow | -$73.0M | -18.5% |
| Financing Cash Flow | -$168.6M | +33.5% |
| Free Cash Flow | $180.3M | +80.4% |
| -43.2% |
| EPS (Basic) | $0.20 | -25.9% |
| EPS (Diluted) | $0.20 | +5.3% |
| Long-term Debt |
| $0 |
| — |
| Total Liabilities | $282.8M | -6.4% |
| Stockholders' Equity | $541.7M | -12.2% |